Create account

Coverage dated August 20, 2026 to August 24, 2026

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

Headline from MedicalXpress

Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill.

MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

4 articles, oldest first.

  1. MedicalXpress

    How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill.

  2. Sun Times

    How much of a cancer drug do patients need? U. of C. doctor, others challenge the FDA, drugmakers on dosing. (opens Sun Times)

    Published

    Sun Times's feed description

    Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.